Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3911 ARTÍCULOS , VIENDO DEL 601 AL 615

Bilateral pedunculopontine nucleus stimulation for progressive supranuclear palsy

Doshi PK, Desai JD, Karkera B, Wadia PM.

Stereotact Funct Neurosurg. 2015;93(1):59-65. doi: 10.1159/000368702. Epub 2015 Jan 31.

Effects of L-Dopa and pramipexole on plasticity induced by QPS in human motor cortex

Enomoto H, Terao Y, Kadowaki S, Nakamura K, Moriya A, Nakatani-Enomoto S, Kobayashi S, Yoshihara A, Hanajima R, Ugawa Y.

J Neural Transm (Vienna). 2015 Sep;122(9):1253-61. doi: 10.1007/s00702-015-1374-8. Epub 2015 Feb 7.

Parkinson disease GWAS: the question of lumping or splitting is back again

Simón-Sánchez J, Gasser T.

Neurology. 2015 Mar 10;84(10):966-7. doi: 10.1212/WNL.0000000000001345. Epub 2015 Feb 6.

Supraventricular Tachycardia Cardioverted by an Automated External Debrillator in a 9-year-old Male with a History of Wolff-Parkinson-White Syndrome

Cortez E, Davis J, Keseg D.

Prehosp Emerg Care. 2015 Jul-Sep;19(3):448-50. doi: 10.3109/10903127.2014.995849. Epub 2015 Feb 9.

Effect of creatine monohydrate on clinical progression in patients with Parkinson disease: a randomized clinical trial

Writing Group for the NINDS Exploratory Trials in Parkinson Disease (NET-PD) Investigators; Kieburtz K, Tilley BC, Elm JJ, Babcock D, Hauser R, Ross GW, Augustine AH, Augustine EU, Aminoff MJ, Bodis-Wollner IG, Boyd J, Cambi F, Chou K, Christine CW, Cines M, Dahodwala N, Derwent L, Dewey RB Jr, Hawthorne K, Houghton DJ, Kamp C, Leehey M, Lew MF, Liang GS, Luo ST, Mari Z, Morgan JC, Parashos S, Pérez A, Petrovitch H, Rajan S, Reichwein S, Roth JT, Schneider JS, Shannon KM, Simon DK, Simuni T, Singer C, Sudarsky L, Tanner CM, Umeh CC, Williams K, Wills AM.

JAMA. 2015 Feb 10;313(6):584-93. doi: 10.1001/jama.2015.120.

Eltoprazine counteracts l-DOPA-induced dyskinesias in Parkinson's disease: a dose-finding study

Svenningsson P, Rosenblad C, Af Edholm Arvidsson K, Wictorin K, Keywood C, Shankar B, Lowe DA, Björklund A, Widner H.

Brain. 2015 Apr;138(Pt 4):963-73. doi: 10.1093/brain/awu409. Epub 2015 Feb 10.

Retromer in Alzheimer disease, Parkinson disease and other neurological disorders

Small SA, Petsko GA.

Nat Rev Neurosci. 2015 Mar;16(3):126-32. doi: 10.1038/nrn3896. Epub 2015 Feb 11.

[The genetics of antipsychotic-related movement disorders]

Bakker PR, van Os J, van Harten PN.

Tijdschr Psychiatr. 2015;57(2):114-9.

[Dilemmas in the treatment of psychiatric symptoms in patients with Parkinson's disease]

Leentjens AF, van den Heuvel OA.

Tijdschr Psychiatr. 2015;57(2):138-42.

Dopamine receptors - IUPHAR Review 13

Beaulieu JM, Espinoza S, Gainetdinov RR.

Br J Pharmacol. 2015 Jan;172(1):1-23. doi: 10.1111/bph.12906.

La FAM fatale: USP9X in development and disease

Murtaza M, Jolly LA, Gecz J, Wood SA.

Cell Mol Life Sci. 2015 Jun;72(11):2075-89. doi: 10.1007/s00018-015-1851-0. Epub 2015 Feb 12.

The safety of istradefylline for the treatment of Parkinson's disease

Müller T.

Expert Opin Drug Saf. 2015 May;14(5):769-75. doi: 10.1517/14740338.2015.1014798. Epub 2015 Feb 13.

Sterile cyst formation after intrathecal stem cell transplant for Parkinson's disease: A case presentation and literature review

Al-Tawfiq JA, Banda RW, Ghandour J.

J Infect Public Health. 2015 Jul-Aug;8(4):382-5. doi: 10.1016/j.jiph.2014.12.001. Epub 2015 Feb 10.

Role of apomorphine in the treatment of Parkinson's disease

Boyle A, Ondo W.

CNS Drugs. 2015 Feb;29(2):83-9. doi: 10.1007/s40263-014-0221-z.

Nociceptin/orphanin FQ-NOP receptor system in inflammatory and immune-mediated diseases

Gavioli EC, de Medeiros IU, Monteiro MC, Calo G, Romão PR.

Vitam Horm. 2015;97:241-66. doi: 10.1016/bs.vh.2014.11.003. Epub 2015 Jan 14.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias